Australia markets closed

Mega Genomics Limited (6667.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
9.790-0.200 (-2.00%)
At close: 03:59PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 2.31B
Enterprise value 1.80B
Trailing P/E 63.65
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.47
Price/book (mrq)3.27
Enterprise value/revenue 10.82
Enterprise value/EBITDA 31.23

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-4.21%
S&P500 52-week change 323.76%
52-week high 312.400
52-week low 37.680
50-day moving average 39.467
200-day moving average 38.899

Share statistics

Avg vol (3-month) 373.81k
Avg vol (10-day) 366.8k
Shares outstanding 5236.43M
Implied shares outstanding 6258.01M
Float 8130.33M
% held by insiders 147.80%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 19.85%
Operating margin (ttm)-16.28%

Management effectiveness

Return on assets (ttm)2.19%
Return on equity (ttm)4.76%

Income statement

Revenue (ttm)151.3M
Revenue per share (ttm)0.71
Quarterly revenue growth (yoy)9.00%
Gross profit (ttm)N/A
EBITDA 34.54M
Net income avi to common (ttm)30.04M
Diluted EPS (ttm)0.150
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)526.27M
Total cash per share (mrq)2.21
Total debt (mrq)48.56M
Total debt/equity (mrq)7.53%
Current ratio (mrq)5.84
Book value per share (mrq)2.71

Cash flow statement

Operating cash flow (ttm)163.68M
Levered free cash flow (ttm)98.11M